Jung HC, Eckmann L, Yang SK, Panja A, Fierer J, Morzycka-Wroblewska E, Kagnoff MF: A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion
Cohen, 2002
To get it approved, you would need to: Buy the patent (its for sale) Figure out a specific disease indication to apply for BPC-157 approval Hire a research team to run phase 1, 2, 3 trials The financial incentives make it so that BPC-157 will likely never go through the full FDA approval process, which is a shame given how promising this compound is
Over and over again, the FDA came back to a major sticking point: Its unclear, chemically, what these peptides even are
By addressing trauma, patients often have a better chance of beating addiction
Proposal of a modified Child-Turcotte-Pugh scoring system and comparison with the model for end-stage liver disease for outcome prediction in patients with cirrhosis
